Estados Unidos · Bolsa y Finanzas · Morningstar

Celaid Therapeutics Completes Second Close of Series B Financing Round

Publicado por Morningstar · Estados Unidos hace 8 h

TOKYO, Oct. 4, 2026 /PRNewswire/ -- Celaid Therapeutics Inc. (Head Office: Bunkyo-ku, Tokyo, Japan; President and CEO: Nobuyuki Arakawa; "Celaid") today announced the completion…

Leer el artículo completo en Morningstar Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.morningstar.com)

Celaid Therapeutics Completes Second Close of Series B Financing Round

También te puede interesar

Zcash gets a Washington lobbyist to push crypto policy

Air Force removes all bombers from British base and redeploys them to the U.S. after a planned terror attack linked to Iran was foiled

Fuel Price Shock Pushes Global Gas Car Sales Below 50% for First Time

U.K. is said to plan tariffs on Chinese EVs under pressure from EU

Supreme Court Justice Alito said he's 'thought about' retirement as Senate control hangs in balance

P.&G.’s Chief on Whether Brand Loyalty Is Enough When Prices Keep Climbing

Celaid Therapeutics Completes Second Close of Series B Financing Round

Compartir

También te puede interesar

Zcash gets a Washington lobbyist to push crypto policy

Air Force removes all bombers from British base and redeploys them to the U.S. after a planned terror attack linked to Iran was foiled

Fuel Price Shock Pushes Global Gas Car Sales Below 50% for First Time

U.K. is said to plan tariffs on Chinese EVs under pressure from EU

Supreme Court Justice Alito said he's 'thought about' retirement as Senate control hangs in balance

P.&G.’s Chief on Whether Brand Loyalty Is Enough When Prices Keep Climbing